Proud to see this work finally published!
Grateful to all the colleagues who took part to this journey 💪
Nonpeptidic Irreversible Inhibitors of SARS-CoV-2 Main Protease with Potent Antiviral Activity | Journal of Medicinal Chemistry https://t.co/C7E382T7L2
Check out our latest paper on the binding mode of A2A antagonist and clinical candidate Etrumadenant. Thanks to everyone involved!
https://t.co/tzTIba8NEi
The @ACSPublications#BonnSymposium was a great opportunity to learn new science, to meet new people and most importantly to collaborate with my colleagues of Prof. Christa E. Müller working group for the Co-organization of the whole symposium.
Looking forward to the next event!
Phantastic conclusion of the @ACSPublications#Bonnsymposium with a talk by Prof. Christa E. Müller regarding purinergic signaling and medicinal chemistry methods @Mueller_AG
I have another opening for a fully funded PhD position dealing with the biological evaluation of carborane-containing selective HDAC inhibitors #borinostats. This project could be integrated into #GRK2873. DM me if you are interested in this project. Please RT!
Unbelievable experience in #Rome!
140 #scientists from 40 countries reunited as a big family to share their expertise and daily effort to "shape the #medicinalchemistry of the new decade"! If these are premises, our health is in good hands..
#MMSC22@Molecules_MDPI
👏On behalf of the #Secretariat of the 3rd #MMCS2022: Shaping #MedicinalChemistry for the New Decade, we would like to sincerely thank our chairs, committee members, speakers, sponsors, and all the attendees, for your participation.
🎉See you all at the next edition!!